in order to maintain constant pH. Table I shows the effect of various buffer concentrations on the pH of five typical urine samples. The system previously used (b) does not always bring the pH of the urine mixture within the required limits of 4.3-4.8 (Boyland, Wallace and Williams, 1955) but, by using 0-2 M acetate buffer (c) the required conditions can be established. Under these conditions neither the original alkaline buffer (d) nor a buffer of twice its strength (e) is sufficiently strong to give a final pH within the range 10.0-10.5. The system (g) was finally selected as the one giving the most constant pH conditions. f. Urine + substrate + 0 2 Macetatebuffer + 10%Na2CO310H20 10-1 10.0 9* 7 10 0 9. 95 g. Urin3 + substrate -0 2Macetatebuffer + 10%Na2CO3 10 3 10-30 10.10 10-30 10 25 (anhyd.) The stability of the phenolphthalein colour at pH values above 9.5 has been investigated as this colour tends to fade at high pH. The colour produced by a series of standard enzyme solutions was investigated at pH values between 9.5 and 11-5 and found to be maximal between pH 10.2 and 10.6. The phenolphthalein colour is stable for 2 hours within the pH range 10-10.5 so the system (g) ( Table I) is satisfactory and has been used throughout this work.
Urine (1 ml.) acetate buffer (1 ml.) (0-2 M, pH 4-5) and substrate solution (1 ml. 0.05 per cent) were incubated in stoppered tubes for 18 hours at 37°in a water bath, urine (1 ml.) was added to the blank and sodium carbonate solution (1 ml. 10 per cent Na2CO3) was added to each. The tubes were centrifuged and the duplicates read against the blank on a Unicam S.P. 500 spectrophotometer at 550 m/a. The activity was expressed in units, 1 unit liberating 1 /ug. of phenolphthalein per hour at 37°.
Owing to the modification of the method of estimation, the units are different from those used previously (Boyland, Wallace and Williams, 1955) , so that the normal range (Table II) is now taken as 0.05-1*2 units/ml. of urine. Values in the pH range of 5.0-7.0 are regarded as normal and deviation from this range is an indication of infection of the urine. The specific gravity of the urine provides a check on the complete collection of the specimen so that both pH and specific gravity have been quoted for each specimen.
It has been suggested (Boyland et al., 1955; Boyland and Williams, 1956) that both' the metabolism of tryptophan and the 8-glucuronidase activity of the urine play a part in the production or maintenance of bladder tumours. The amount of tryptophan in the diet might affect the apparent urinary /,-glucuronidase activity, because tryptophan metabolites conjugated with glucuronic acid might act as competitive inhibitors. A number of specimens have been examined after dosing the patients with 2 g. of L-tryptophan. Such specimens are indicated in the tables by the presence of the letter T after the figure for urine volume. All specific gravities are given in direct urinometer readings, thus a figure of 10 indicates a specific gravity of 1-010. (Table VII) only 4 have f/-glucuronidase activities within the normal range, with a mean 1-7 units.
Of 11 patients suffering from cancer of the larynx but not cancer of the vocal cord (Table VIII) , 5 had values above the range of healthy subjects, the mean value being 1-6 units. Patients suffering from cancer of the bronchus Of 11 patients suffering from cancer of the bronchus (Table IX) 5 cases have a fl-glucuronidase activity within the normal range and the mean is 1-8 units. Patients suffering from malignant blood diseases The urinary /-glucuronidase activity of 8 out of 10 patients suffering from leukaemia (Table Xa) was above the normal range with an average activity of 1.8 units. Cases 9 and 10 had pyrexia at the time of collection. Of 5 patients suffering from Hodgkin's disease (Table Xb) 4 had activity above the normal range and the average value is 2.5 units. (b) Patients treated with stilboestrol for more than two years.-The mean f8-glucuronidase activity of the urine of a group of 7 patients receiving treatment with stilboestrol for more than two years (Table XIV) (Table XV) show only two of these patients had 8-glucuronidase activities greater than the upper limit of normal and in both of these cases the patients had raised temperatures at the time of collection of the specimen. The average i8-glucuronidase activity of this group was 1-1 units. The method of estimation has been modified so that even alkaline urine specimens, previously discarded may now estimated, but in very alkaline conditions the enzyme is not stable. The urinary ,b-glucuronidase activities of patients varied considerably with the site of the tumour but in no group of cases were all the results outside the normal range. This suggests that f,-glucuronidase activity could not be used as a diagnostic method, although in some types of cancer such estimations might prove useful for prognostic purposes.
The average urinary f-glucuronidase activity in cancer of various sites within the alimentary tract is, in general, near the upper limit of normal but the activity in cases of cancer of the colon is low. Cancer of the thyroid also produced a decrease in urinary 8-glucuronidase activity but cases of cancer of larynx, bronchus, oesophagus, prostate and testicle show an increased activity.
Cases of leukaemia and of Hodgkin's disease also exhibit an increase in urinary ,-glucuronidase activity but in these cases there is generally an increase in the patient's temperature, which is known to increase I-glucuronidase excretion (Boyland and Williams, unpublished) , so that the increased activity may be due partly to this cause. The connection between malignant blood disease and blood glucuronidase activity and the treatment of these patients with enzyme inhibitors is being investigated.
SUMMARY
(1) The method previously used for the estimation of urinary /-glucuronidase activity has been modified so that it may be applied to alkaline or concentrated urine.
(2) Urinary f,-glucuronidase activities have been investigated in patients suffering from cancer of the alimentary tract, larynx, breast, thyroid, bronchus, testicle, and prostate and also in patients suffering from leukaemia and Hodgkin's disease.
